Alpha Tau Medical (DRTS) filed a registration statement Monday for the sale of up to 3.5 million common shares from time to time on behalf of selling shareholders.
The registration covers 3.2 million shares that will be issued to Oramed upon exercise of IR/PR warrants and 226,202 shares issued to A & M Construction, according to Alpha Tau.
The company said it will not receive any of the proceeds from the sale of the shares and expects to receive about $12.3 million from the exercise of warrants.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.